
A verruca is essentially a collection of skin cells infected by the Human Papilloma Virus or verrucae virus. These infected cells remain in the outer layers of the skin (the epidermis), away from detection by the body’s immune system; explaining why verrucae can be so resilient. Verrucae usually present as a plaque of hard skin with an irregular border and can have black dots (blood vessels) scattered throughout.
Verrucae can be very painful and can appear on any part of the body.
Verrutop is a new treatment in the UK and is a Class 2A Healthcare Product, which should only be used by a qualified medical professional
Verrutop in a unique combination of three organic acids, namely lactic, acetic and oxalic which are combined with copper and zinc salts (accelerants) plus nitric acid to produce “Nitic Zinc Complex”.
This Complex causes two keys processes …
A study involving 210 patients with 766 verrucae demonstrated an 89.3% clearance rate within 6 treatment sessions.
Patients will be booked in for an Initial Assessment. During this appointment the podiatrist will assess if you are suitable for Verrutop.
Verrutop is applied to the verrucae via a small capillary tube after any overlying callous is reduced.The surface of the verruca is covered in the solution. The verruca may change colour and appear a white/yellow colour. Patients will be advised to apply surgical spirit to the verruca twice a day between treatments to aid the dehyration process. The process will be repeated every two weeks up to a maximum of six sessions.
In the majority of cases treatment is painless hover some patients may experience a slight tingling or burning sensation. If this is the case, it is short term.
Verrutop is a safe topical treatment however may not suitable for all patients. Verrutop should not be used: